Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 12, 1997, Pages 3639-3645

  Sigari, Farhad ^a   Lee, Chris ^a   Witztum, Joseph L ^a   Reaven, Peter D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoantibodies; Chemotaxis; Lipid peroxidation; Modified LDL; Monocyte adhesion

Indexed keywords

AGAROSE; ALPHA TOCOPHEROL; ARACHIDONATE 15 LIPOXYGENASE; BETA GALACTOSIDASE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; POLYACRYLAMIDE GEL; PROBUCOL; PROTEIN; SCAVENGER RECEPTOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL CELL; ARTICLE; CELL ADHESION; CHEMOTAXIS; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FIBROBLAST; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SWINE;

EID: 0031471792     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.12.3639     Document Type: Article

References (14)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20:707-727.
3. Navab M, Berliner JA, Watson AD, Hama S, Territo MC, Lusts AJ, Shin DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM. The yin and yang of oxidation in the development of the fatty streak. Arterioscler Thromb Vasc Biol. 1996;831-842.
4. Berliner JA, Territo M, Almada L, Carter A, Shafonsky E, Fogelman AM. Monocyte chemotactic factor produced by endothelial cells. Arteriosclerosis. 1986;6:254-258.
5. Navab M, Hough GP, Stevenson LW, Drinkwater DC, Laks H, Fogelman AM. Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J Clin Invest. 1988;82:1853-1863.
6. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H, Fogelman AM. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991;88:2039-2046.
7. Navab M, Hama SY, Nguyen TB, Fogelman AM. Monocyte adhesion and transmigration in atherosclerosis. Coron Artery Dis. 1994;5:198-204.
8. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990;344:254-257.
9. Steinbrecher UP. Role of Superoxide in endothelial-cell modification of low density lipoprotein. Biochim Biophys Acta. 1988;959:20-30.
10. Cathcart MK, McNally AK, Morel DW, Chisolm GM. Superoxide anion participation in human monocyte-mediated oxidation of low density lipoprotein and conversion of low density lipoprotein to a cytotoxin. J Immimol. 1989;142:1963-1969.
11. Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GA. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb Vasc Biol. 1991;11:1700-1711.
12. Parthasarathy S. Oxidation of low density lipoprotein by thiol compounds lead to its recognition by the acetyl LDL receptor. Biochim Biophys Acta. 1987;917:337-340.
13. Belkner J, Wiesner R, Rathman J, Barnett J, Sigal E, Kuhn H. Oxygenation of lipoproteins by mammalian lipoxygenases. Eur J Biochem. 1993;213:251-261.
14. Folcik VA, Nivar-Aristy R, Krajewski L, Cathcart MK. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J Clin Invest. 1995;96:504-510.